The fibrillation of atrium and stroke


Cite item

Full Text

Abstract

The article considers fibrillation of atrium as one of the mostly frequent alternative of cardiac rhythm disturbance and its significance in genesis of development of cardio-embolic stroke. It is emphasized that stroke risk in patients with atrium fibrillation increases in case of occurrence of concurrent arterial hypertension, diabetes mellitus and increasing of age. It is marked that stroke developed against the background of atrium fibrillation proceeds as a rule in a more severe way and is accompanied with higher disability and lethality than stroke developed against the background of normal sinus rhythm or in case of valvar origin of emboli that is caused in average large size of emboli. The area of cerebral infarction developed because of embolism is commonly larger than in case of thrombolitic infarction and at affection of the same cerebral vessel. The main technique of diagnostic in case of cardio-embolic stroke is computer or magnetic resonance tomography of brain. These examinations mostly visualize neatly cuneiform delineated zone of ischemia at the border of white and gray substances of brain. The cardiological examination us implemented too (ECG, echoCG). Monitoring of patients with cardio-embolic stroke developed against the background of atrium fibrillation is carried out according general principles implemented in case of ischemic stroke. To prevent recurrent cardioembolism per oral anticoagulants are applied in most cases.

About the authors

Igor’ V. Damulin

The I.M. Sechenov first Moscow state medical university of Minzdrav of Russia

Email: damulin@mmascience.ru
MD, PhD, DSc. 119991 Moscow, Russia

D. A Andreev

The I.M. Sechenov first Moscow state medical university of Minzdrav of Russia

Кафедра неотложной и профилактической кардиологии 119991 Moscow, Russia

References

  1. Bal S., Ojha P., Hill M.D. Stroke prevention treatment of patients with atrial fibrillation: old and new. Curr. Neurol. Neurosci. Rep. 2011; 11: 15-27.
  2. Ferro J.M. Brain embolism. Answers to practical questions. J. Neurol. 2003; 250: 139-47.
  3. Bansil S., Karim H. Detection of atrial fibrillation in patients with acute stroke. J. Stroke Cerebrovasc. Dis. 2004; 13(1): 12-5.
  4. Lairikyengbam S.K.S., Anderson M.H., Davies A.G. Present treatment options for atrial fibrillation. Postgrad. Med. J. 2003; 79: 67-73.
  5. Hart R.G. Secondary prevention of stroke in patients with atrial fibrillation: what every neurologist should know. Pract. Neurol. 2003; 3: 260-7.
  6. Hart R.G. Atrial fibrillation and stroke prevention. N. Engl. J. Med. 2003; 349(11): 1015-6.
  7. Mobius-Winkler S., Schuler G.C., Sick P.B. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device. Curr. Opin. Neurol. 2008; 21: 64-9.
  8. Perez-Gomez F., Bover-Freire R. Atrial fibrillation. From physiopathology to treatment. Madrid: Tallers Grafi cos G.B.; 2010.
  9. The Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation. A systematic review. Neurology. 2007; 69(6): 546-54.
  10. Thomson R. How can epidemiological studies help us to prevent stroke? The example of atrial fi brillation. Age Ageing. 2002; 31(S3): 9-16.
  11. Wang D., Liu M., Hao Z., Tao W. Association between reduced kidney function and clinical outcomes after ischaemic stroke with atrial fibrillation. Eur. J. Neurol. 2014; 21: 160-6.
  12. Inoue T., Kimura K., Minematsu K., Yamaguchi T., Japan Multicenter Stroke Investigators’ Collaboration (J-MUSIC). Clinical features of transient ischemic attack associated with atrial fibrillation: analysis of 1084 TIA patients. J. Stroke Cerebrovasc. Dis. 2004; 13(4): 155-9.
  13. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch. Intern. Med. 1994; 154: 1449-57.
  14. Aminoff M. Neurological dysfunction and kidney disease. In: Aminoff M.G., ed. Neurology and General Medicine. 4th ed. Philadelphia: Churchill Livingstone; 2008; 18: 327-46.
  15. Miller V.T., Rothrock J.F., Pearce L.A., Feinberg W.M., Hart R.G., Anderson D.C. Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators. Neurology. 1993; 43(1): 32-6.
  16. Kanter M.C., Tegeler C.H., Pearce L.A., Weinberger J., Feinberg W.M., Anderson D.C. et al. Carotid stenosis in patients with atrial fibrillation: prevalence, risk factors and relationship to stroke in the Stroke Prevention in Atrial Fibrillation Study. Arch. Intern. Med. 1994; 154(12): 1372-7.
  17. Cheshire W.P., Saper C.B. The insular cortex and cardiac response to stroke. Neurology. 2006; 66: 1296-7.
  18. Daniele O., Caravaglios G., Fierro B., Natale E. Stroke and cardiac arrhythmias. J. Stroke Cerebrovasc. Dis. 2002; 11(1): 28-33.
  19. Bugnicourt J.M., Rogez R., Guillaumont M.P., Rogez J.C., Canaple S., Godefroy O. Troponin levels help predict new-onset atrial fibrillation in ischaemic stroke patients: a retrospective study. Eur. Neurol. 2010; 63(1): 24-8.
  20. Ueno Y., Kimura K., Iguchi Y., Shibazaki K., Inoue T., Urabe T. Right-to-left shunt and lacunar stroke in patients without hypertension and diabetes. Neurology. 2007; 68(7): 528-31.
  21. Hankey G.J. Stroke. Your Questions Answered. Edinburg etc.: Churchill Livingstone; 2002.
  22. Боголепов Н.К. Клинические лекции по невропатологии. М.: Медицина; 1971.
  23. Ay H., Koroshetz W.J., Benner T., Vangel M.G., Melinosky C., Arsava E.M. et al. Neuroanatomic correlates of stroke-related myocardial injury. Neurology. 2006; 66(9): 1325-9.
  24. Bogousslavsky J., Cachin C., Regli F., Despland P.A., Van Melle G., Kappenberger L. Cardiac sources of embolism and cerebral infarction - clinical consequences and vascular concomitants: the Lausanne Stroke Registry. Neurology. 1991; 41(6): 855-9.
  25. Glader E.L., Stegmayr B., Norrving B., Terént A., Hulter-Asberg K., Wester P.O. et al. Large variations in the use of oral anticoagulants in stroke patients with atrial fibrillation: a Swedish national perspective. J. Intern. Med. 2004; 255(1): 22-32.
  26. Широков Е.А. Профилактика инсульта: актуальные проблемы и новые тенденции. Русский медицинский журнал. 2013; 10: 466-9.
  27. Ашихмин Я.И., Щекочихин Д.Ю. Индивидуализированная антитромботическая терапия при фибрилляции предсердий. Фарматека. 2013; 18(271): 119-23.
  28. Морозова Т.Е., Андрущишина Т.Б. Профилактика тромбоэмболических осложнений у пациентов с фибрилляцией предсердий. Фарматека. 2014; 9(282): 81-7.

Copyright (c) 2015 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies